ASMLs, Valuation

ASML's Valuation Check: Not Cheap, Not Overpriced, but Caught in a Sector Mood Swing

Published on 07/26/2026 at 12:31 | Redaktion boerse-global.de

ASML shares fell 2.31% even as Intel raised its 2026 investment budget to over $20 billion, highlighting a persistent disconnect between strong fundamentals and weak market sentiment.

ASML Stock Slips Despite Intel's Blockbuster Earnings and Capex Boost
ASML's Valuation Check: Not Cheap, Not Overpriced, but Caught in a Sector Mood Swing Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The disconnect between strong fundamentals and weak share price action has become a recurring theme for ASML. On Friday, the Dutch lithography giant's stock slipped 2.31 percent to €1,545.60, even as Intel — one of its most important customers — delivered a blockbuster earnings report and raised its capital expenditure outlook.

Intel posted second-quarter revenue of $16.1 billion, a 25 percent jump that easily beat the $14.5 billion analysts had penciled in. Adjusted earnings per share of $0.42 nearly doubled the $0.22 consensus estimate. The data center business was the standout, with revenue surging 59 percent to $6.3 billion. More critically for ASML, Intel lifted its 2026 investment budget to over $20 billion, with a significant portion earmarked for chip fabrication equipment and memory chips.

Chief Financial Officer David Zinsner said the company is "aggressively securing orders from our suppliers" and accelerating cleanroom expansion, driven by robust customer demand. He also flagged substantially higher investment levels for 2027.

Yet the market reaction was muted at best. ASML shares managed only a modest pre-market gain of about 1 percent on Friday. Lam Research added 0.4 percent, while KLA and Applied Materials barely budged. Sentiment on Stocktwits remained "bearish" across all four names. One trader summed up the mood: Intel delivered strong numbers, but the response was "piss poor" — echoing the pattern seen after TSMC and ASML's own recent reports.

Should investors sell immediately? Or is it worth buying Asml?

A Pattern That Started With ASML's Own Results

The weakness on Friday extends a sell-off that began after ASML reported its own quarterly numbers on July 15. Profit-taking, a sector-wide rotation away from semiconductor equipment makers, and a generally more cautious risk appetite all converged at that point.

This happened despite ASML raising its 2026 revenue guidance to between €43 billion and €45 billion — well above the previous consensus of €40 billion. Several banks responded by lifting their price targets: Berenberg set €2,100, Barclays €2,400, Bernstein the Street-high €2,500, and UBS raised to €2,250 while maintaining its buy recommendation. Deutsche Bank also reaffirmed its buy rating.

None of that prevented the subsequent selling pressure.

Where the Stock Stands Now

At €1,545.60, ASML trades roughly 11.6 percent below its 52-week high of €1,748, reached in late June. Year-to-date, the stock is still up 67.73 percent, and over the past twelve months it has gained an extraordinary 150.18 percent. The annualized 30-day volatility of over 55 percent underscores just how sensitive the shares have become after such a run.

Intel's investment offensive validates the demand story for lithography equipment across the industry. ASML's own management had already pointed to exceptionally strong order intake extending through 2027 and 2028. The question now is whether investors will continue to use strong sector data as an opportunity to sell, or whether the mood will stabilize around the still-optimistic analyst targets.

Valuation: Not a Bargain, But No Red Flag Either

A fresh valuation analysis offers a nuanced take on where ASML stands. On profitability, assets, and cash flow, the company scores well in only two out of six categories — suggesting an expensive rather than cheap stock.

But the earnings multiple tells a more balanced story. ASML trades at a price-to-earnings ratio of roughly 56.4, close to the industry average of about 57.9 and the peer-group mean of 57.5. A custom fair-value comparison that adjusts for the company's size, margins, and risk profile arrives at a fair P/E of around 55.2. The current share price sits only slightly above that level.

The takeaway: ASML is not dramatically overvalued, but it is no longer a clear bargain either.

The Bull Case vs. The Export Risk

Optimists continue to point to ASML's position at the center of the AI infrastructure buildout. Progress on High-NA EUV technology adoption at customers like Intel supports high expectations for future equipment demand.

Asml at a turning point? This analysis reveals what investors need to know now.

The counterweight is the persistent risk of trade and export restrictions, particularly regarding sales and servicing in China. This uncertainty may limit how much value investors are willing to assign to long-term growth prospects.

Wall Street remains constructive for now. UBS, Barclays, and Morgan Stanley all reaffirmed positive ratings on the stock in the third week of July, apparently viewing export risks as a known and already-priced factor rather than a new threat.

The Second-Half Variables

For a stock that has nearly doubled in the past twelve months, the debate has shifted from pure momentum to sustainability. The central question is whether the current price fully reflects both the High-NA EUV opportunity and the export risks — or whether room remains for further re-rating to the upside.

China export policy and the pace of High-NA EUV adoption are likely to be the two decisive variables for the second half of the year. The coming week will offer an early test of whether investors are ready to look past the recent sector weakness and refocus on the fundamental demand story.

Ad

Asml Stock: New Analysis - 26 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0010273215 | ASMLS | boerse | 69876862 |